A detailed history of Investment Advisory Services Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Investment Advisory Services Inc holds 28,510 shares of ABBV stock, worth $5.01 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
28,510
Previous 30,397 6.21%
Holding current value
$5.01 Million
Previous $5.21 Million 8.0%
% of portfolio
2.01%
Previous 1.92%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $309,166 - $376,135
-1,887 Reduced 6.21%
28,510 $5.63 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $153,551 - $179,313
-992 Reduced 3.16%
30,397 $5.21 Million
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $55,457 - $63,188
-347 Reduced 1.09%
31,389 $5.72 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $29,584 - $33,318
-215 Reduced 0.67%
31,736 $4.92 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 0.08%
31,951 $4.76 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $530 - $659
4 Added 0.01%
31,926 $4.3 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $34,851 - $40,136
-241 Reduced 0.75%
31,922 $5.09 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $17,565 - $21,065
127 Added 0.4%
32,163 $5.2 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $5,368 - $6,157
40 Added 0.13%
32,036 $4.3 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $88,214 - $112,149
-641 Reduced 1.96%
31,996 $4.9 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $13,593 - $16,866
103 Added 0.32%
32,637 $5.29 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $49,525 - $62,663
461 Added 1.44%
32,534 $4.41 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $5,745 - $6,522
-54 Reduced 0.17%
32,073 $3.46 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $85,640 - $95,408
-814 Reduced 2.47%
32,127 $3.62 Million
Q4 2020

Mar 10, 2021

SELL
$80.49 - $108.67 $3,702 - $4,998
-46 Reduced 0.14%
32,941 $3.53 Million
Q3 2020

Mar 10, 2021

BUY
$85.91 - $100.83 $8,762 - $10,284
102 Added 0.31%
32,987 $2.89 Million
Q2 2020

Mar 10, 2021

BUY
$73.37 - $98.18 $195,164 - $261,158
2,660 Added 8.8%
32,885 $3.23 Million
Q1 2020

Mar 10, 2021

BUY
$64.5 - $97.79 $107,586 - $163,113
1,668 Added 5.84%
30,225 $2.3 Million
Q4 2019

Mar 10, 2021

BUY
$72.13 - $90.25 $2.06 Million - $2.58 Million
28,557 New
28,557 $2.53 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investment Advisory Services Inc Portfolio

Follow Investment Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Advisory Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investment Advisory Services Inc with notifications on news.